country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-187724

Copy Link Print Information

Hydrocortisone caproate

Hydrocortisone caproate is an orally active anti-inflammatory corticosteroid ester and an ester derivative of hydrocortisone. Hydrocortisone caproate inhibits granuloma formation, induces hepatic glycogen deposition, and exerts anti-inflammatory activity. Hydrocortisone caproate can be used in research related to hemorrhoids.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 3593-96-2
Formel: C₂₇H₄₀O₆
Molecular Weight:460.60

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

Hydrocortisone caproate Chemical Structure

CAS. Nr.: 3593-96-2

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- In Vivo
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

Alle Endogenous Metabolite Isoform-spezifische Produkte anzeigen :

In Vivo

OthersCarbohydrate Metabolism

Others

Hydrocortisone caproate (125-1000 μg local per pellet; 1000-2000 μg daily subcutaneous; 6-7 days) inhibits cotton pellet-induced granuloma formation in rats, with 54% inhibition at a daily subcutaneous dose of 2000 μg and 35% inhibition at a local dose of 1000 μg per pellet^[1].

Carbohydrate Metabolism

Hydrocortisone caproate (oral; hourly; 5 doses) has equivalent liver glycogen-modulating activity to hydrocortisone alcohol when administered to fasted albino mice^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Holtzman rats (male, 125-150 Gm, subcutaneous cotton pellet granuloma model)^[1]
Dosage:

1000 μg, 500 μg, 250 μg, 125 μg (local per pellet); 2000 μg daily, 1000 μg daily (systemic)
Administration:

local application; subcutaneous injection; daily; 6-7 days
Result:

Inhibited granuloma formation by 35% at 1000 μg local dose.
Inhibited granuloma formation by 15% at 500 μg local dose.
Inhibited granuloma formation by 24% at 250 μg local dose.
Inhibited granuloma formation by 5% at 125 μg local dose.
Inhibited granuloma formation by 54% at 2000 μg daily systemic dose.
Inhibited granuloma formation by 37% at 1000 μg daily systemic dose.

Animal Model:

Albino rats (male, ~200 Gm, diet-induced liver glycogen depletion model)^[1]
Dosage:

1.5 mg hydrocortisone acetate equivalent per 100 Gm
Administration:

subcutaneous; daily; 6 days
Result:

Produced a liver glycogen response of 643 mg reducing substances per 100 Gm body weight above control values.

Animal Model:

Albino rats (male, ~200 Gm, single subcutaneous injection prolonged action model)^[1]
Dosage:

8.25 mg hydrocortisone acetate equivalent per 100 Gm
Administration:

subcutaneous; single dose
Result:

Produced an overall 7-day liver glycogen activity (area under curve) of 737.
Resulted in 5.5 mg of steroid absorbed over 7 days.
Achieved an activity per mg absorbed of 135 (calculated as hydrocortisone acetate).

Related Protocols :

Chemical Information

CAS. Nr. 3593-96-2
Molecular Weight 460.60
Formel C₂₇H₄₀O₆
SMILES

C[C@@]12[C@](CC[C@]2(O)C(COC(CCCCC)=O)=O)([H])[C@@]3([H])[C@]([C@@]4(C(CC3)=CC(CC4)=O)C)([H])[C@H](C1)O
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Handling Instructions (2659 KB)

Verweise

[1]. Winter C A, Porter C C. Effect of alterations in side chain upon anti-inflammatory and liver glycogen activities of hydrocortisone esters[J]. Journal of the American Pharmaceutical Association (Scientific ed.), 1957, 46(9): 515-519.

[2]. Amin M, Jakobs U. Dünnschichtchromatographische trennung mehrerer wirkstoffe aus salben und suppositorien und ihre anschliessende direkte quantitative analyse nach der remissionsmethode[J]. Journal of Chromatography A, 1977, 131: 391-398.

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen